MONSO: Monsenso A/S - Summary | Jitta

Monsenso A/S

DNK:MONSO

Price
kr0.19
Loss Chance
57.9%
1.66JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
120 / 124
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (15)
Recent Business Performance (19)
Financial Strength (45)
Return to Shareholders (0)
Competitive Advantage (28)
Jitta Signs
SG&A to SalesDecreasing
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 21.71% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
1.66
100.00%
4.95
38.73%
Health Care Technology
2.14
58.92%
COMPANY DESCRIPTION
Monsenso A/S develops and sells digital health solution for the treatment of depression, bipolar disorder, anxiety, schizophrenia, borderline personality disorder, and addiction and substance abuse in Denmark. The company offers Monsenso app for individuals that collects patient-reported and sensor data providing insights into symptoms, adherence, and outcomes. It also provides Monsenso solution, a software as a medical device for mental health professionals application that has data collection, direct messaging, visualization and feedback, psychoeducation and cognitive behavioral therapy, medication reminders, task reminders, consultation prepration, and platform integration that allows monitor patients remotely. In addition, the company offers Monsenso app for carers. Monsenso A/S was incorporated in 2013 and is based in Frederiksberg, Denmark.